Antheia

Biotechnology · Menlo Park, CA · Founded 2013 · Privately Held (backing)

Operator of a biotechnology company intended to develop plant-inspired medicines. Antheia is based in Menlo Park, CA and was founded in 2013. Its last reported valuation was $240 million in Jun 2021. It has raised $176 million across 5 recorded rounds; the latest was an $80 million Series C in Jan 2026.

Last reported valuation
$240.0M
Oct 2026
Priced at
—
Total raised
$176.2M
Last round
Later Stage VC (Series C)
Jan 2026

Who backs Antheia?

23 investors
InvestorType
US National Science FoundationOther
Viking Global InvestorsAsset manager
National Institutes of HealthOther
In-Q-TelVenture capital
Western Technology InvestmentVenture capital
EDBIVenture capital
Irregular ExpressionsVenture capital
Sherpalo VenturesVenture capital
Lam CapitalVenture capital
Echo Investment CapitalPE / buyout
+ 13 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Antheia investors

23 investors are on record for Antheia, including US National Science Foundation, Viking Global Investors, National Institutes of Health and In-Q-Tel. By type, the record holds 6 venture capital firms and 2 family offices. The Series C in Jan 2026 drew 10 investors.

Free account
More of Antheia with a free account
  • ·The complete investor list: 23 names
  • ·Watch Antheia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 23 firms already write checks for companies like Antheia in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View